Ann: Company Transformation Announcement, page-73

https://medcanaustralia.com.au/

Medcan Australia was granted the 13th Cultivation and Production licence from the Office of Drug Control in November 2017 with a nominated commencement start date for production being the 1st of July 2018.

Might be a hectic open but we are still seeing a set up where no revenue will come in for some time and will require the funds of shareholders with no guarantees.

It’s a good ann because it makes them competitive but it’s not definitive and definitely still has an amount of risk.